510(k) device
Assert-IQ (DM5100)
Abbott Medical · Recorder, Event, Implantable Cardiac, (With Arrhythmia Detection) (MXD, Class II) · First FDA decision Dec 18, 2025, newest Dec 18, 2025Atrial fibrillation
Last checked: Nov 21, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
2
Naming "Assert-IQ"
MAUDE reports
2,576
Brand "Assert-IQ", since 2015
PubMed studies
1
Mentioning "Assert-IQ"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Assert-IQ (DM5100)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Assert-IQ (DM5100)510(k)
K253516 · Decided Dec 18, 2025 · 36 days after receipt
Device type: Recorder, Event, Implantable Cardiac, (With Arrhythmia Detection) (MXD) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Assert-IQ", any status and sponsor, newest update first.
- Gapless ECG-Monitoring for Stroke Prevention by Atrial Fibrillation Detection (GEMS-PAF-randomized Trial) - A Multi-centre, Randomized Controlled Outcome Trial.Pivotal-lookingNot yet recruiting
Medical University of ViennaAcademic, hospital or other
NCT07941167 · 442 participants (planned) · Start Nov 20, 2026 · Primary completion Nov 20, 2029
Device: Ultra-early Implantable loop recorder (ILR) implantation · For: Ischaemic Stroke; TIA (Transient Ischemic Attack); Atrial Fibrillation (Paroxysmal) and 9 more
Sites: Vienna, Austria
1 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Assert-IQ", and for the whole product code for context.
This brand
2,576 reports: 2,282 malfunction, 292 injury, 0 death
Whole product code MXD
13,376 reports: 11,084 malfunction, 2,288 injury, 3 death
Newest reports for this brand
- Assert-IQ¿ ICMMalfunction
2017865-2026-22982 · Received Oct 30, 2026
Device type: Recorder, Event, Implantable Cardiac, (Without Arrhythmia Detection) (MXC)
Device problem as coded: Premature Discharge of Battery
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Assert-IQ"[tiab]. The summary above synthesizes these.
- Atrial fibrillation detection performance of an insertable cardiac monitor: Results from an Assert-IQ post-market clinical study and a novel artificial intelligence algorithm.
Birgersdotter-Green U, Ojeda W, Manyam H, et al. · Heart Rhythm O2 · 2026
Other devices of this type
Also filed under product code MXD.
- LINQ II Insertable Cardiac Monitor (ICM) (LNQ22)Medtronic, Inc. · 510(k) 2026
- Reveal LINQ Insertable Cardiac MonitorMedtronic, Inc. · 510(k) 2023
- Reveal LINQMedtronic, Inc. · 510(k) 2017
- BioMonitor 2-AF, BioMonitor 2-S, FIT - Fast Insert Tool 1 + 2, SetBiotronik, Inc. · 510(k) 2017
- Biomonitor IV (471155)Biotronik, Inc. · 510(k) 2026
- LUX-Dx Insertable Cardiac MonitorBoston Scientific Corporation · 510(k) 2021
- Biomonitor III, Biomonitor IIImBiotronik, Inc. · 510(k) 2020
- BioMonitorBiotronik, Inc. · 510(k) 2015
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.